FDA's Counterfeit Alert Network is a coalition of health profession and consumer groups. The Network has three goals:
- To disseminate alert messages to a wide audience about specific counterfeit drug incidents in the United States and measures to take to minimize exposure (recall information, for example);
- To develop educational information about the roles and responsibilities that consumers, pharmacists, other health professionals, and wholesalers should play to identify counterfeit drugs, report suspect counterfeit drugs, and prevent them from entering the U.S. drug distribution system; and,
- To develop a network of national organizations, consumer groups, and industry representatives to help distribute the information.
These groups are current Counterfeit Alert Network members:
- American Academy of Family Physicians
- American Academy of Nurse Practitioners
- American Academy of Physician Assistants
- American College of Clinical Pharmacy
- American College of Physicians
- Academy of Managed Care Pharmacy
- American Medical Association
- American Pharmacist Association
- American Society for Aesthetic Plastic Surgery
- American Society for Health-System Pharmacists
- Healthcare Distribution Management Association
- National Association of Chain Drug Stores
- National Association of Pediatric Nurse Practitioners
- National Community Pharmacists Association
- National Consumer League
- Partnership for Safe Medicines
- Physicians Coalition for Injectable Safety
In the event of a confirmed counterfeit case in the United States, FDA will send an alert to these partners. The Agency also will send partners a notice if a counterfeit incident is confirmed elsewhere in the world that could affect U.S. partners.
If your organization is interested in becoming a partner in the Counterfeit Alert Network, please contact CDERCompliance@fda.hhs.gov.